Wikipedia -WSS

Wikipedia

author：focus 2025-10-04 11:31:10 - browse：5

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Police still searching for prisoner who escaped from NYC hospital

The biotech scorecard for the 2nd quarter: 12 industry events to watch

EMA weighs against approval for Mirati's lung cancer drug

Wegovy’s successful heart trial raises vital question about weight loss

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Wikipedia

Wikipedia

focus

Supreme Court strikes down use of affirmative action

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

In Memoriam: Notable people who died in 2023

For Cytokinetics, FDA rejection of heart drug would help, not hinder

State Dept. review finds Biden bears some blame for Afghanistan failures

Pfizer's RSV vaccine recommended for approval in Europe

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New chief aims to remake Sanofi Genzyme

Heart attack and stroke risk calculators need revising

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

entertainment

Drastic changes should bring profitability, startup health insurers say

South Korea throws huge K

NIH trials fail to test meaningful long Covid therapies, experts say

FDA panel issues narrow recommendation for Covid vaccine booster doses

Prosecutors say FTX founder Sam Bankman

Listen: BridgeBio's big week & Lilly's Alzheimer's data

explore

hotspot

focus

explore